ライフサイエンスコーパス: cognitive behavioral therapy

1 treatment (the combination of fluoxetine and cognitive behavioral therapy).

2 s enhanced MC (eg, delivered with adjunctive cognitive behavioral therapy).

3 scranial magnetic stimulation, and web-based cognitive behavioral therapy.

4 0-225 mg); or (4) switch to venlafaxine plus cognitive behavioral therapy.

5 All patients also received individual cognitive behavioral therapy.

6 ective serotonin reuptake inhibitor drugs or cognitive behavioral therapy.

7 abstinence from binge eating and purging to cognitive behavioral therapy.

8 so participated in weekly standardized group cognitive behavioral therapy.

9 s used in conjunction with weekly outpatient cognitive behavioral therapy.

10 MRI test-retest, patients underwent a 9-week cognitive behavioral therapy.

11 weeks and participated in weekly individual cognitive behavioral therapy.

12 ht twice daily) or placebo along with weekly cognitive-behavioral therapy.

13 ) or placebo for 11 weeks, plus standardized cognitive-behavioral therapy.

14 double placebo (N=39) while receiving weekly cognitive-behavioral therapy.

15 o therapist-led and therapist-assisted group cognitive-behavioral therapy.

16 dividual psychotherapy, pharmacotherapy, and cognitive-behavioral therapy.

17 oms that are refractory to pharmacologic and cognitive-behavioral therapies.

18 supportive psychotherapy compared to that of cognitive-behavioral therapy; 2) whether a two-stage med

19 Anxiety symptoms improved with cognitive behavioral therapy (246 randomized controlled

20 -40 mg); (2) switch to a different SSRI plus cognitive behavioral therapy; (3) switch to venlafaxine

21 Cognitive behavioral therapy achieved lower posttreatmen

22 onged tobacco abstinence rates compared with cognitive behavioral therapy alone after 1 year of treat

23 Under SC, cases were referred to cognitive behavioral therapy, an evidence-based therapy

24 eceived 12-weeks' open-label varenicline and cognitive behavioral therapy and 87 met abstinence crite

25 l treatment with an SSRI, the combination of cognitive behavioral therapy and a switch to another ant

26 or matched placebo, plus weekly computerized cognitive behavioral therapy and biweekly individual cou

27 Psychological interventions such as cognitive behavioral therapy and contingency management

28 treatment were randomly assigned to receive cognitive behavioral therapy and double-blind vareniclin

29 ted with 12 weekly sessions of manual-guided cognitive behavioral therapy and either 50 mg/day of nal

30 Low-quality evidence suggested that cognitive behavioral therapy and exercise, including min

31 s which have shown promising results include cognitive behavioral therapy and graded exercise therapy

32 terventions include gastrointestinal-focused cognitive behavioral therapy and gut-directed hypnothera

33 The dissemination of computer-based cognitive behavioral therapy and improved evidence suppo

34 Cognitive behavioral therapy and interpersonal psychothe

35 dence that counseling interventions, such as cognitive behavioral therapy and interpersonal therapy,

36 Thus, the therapeutic effects of cognitive behavioral therapy and naltrexone may be syner

37 and SUDs, and treatment modalities including cognitive behavioral therapy and pharmacotherapy demonst

38 Substantial evidence supports the use of cognitive behavioral therapy and selective serotonin reu

39 Although cognitive behavioral therapy and selective serotonin-reu

40 ther supported by use of the same treatments-cognitive behavioral therapy and serotonin reuptake inhi

41 Both cognitive behavioral therapy and sertraline reduced the

42 Other forms of cognitive behavioral therapy and topiramate also increas

43 have emerged as having established efficacy: cognitive-behavioral therapy and antidepressant medicati

44 imia yield extremely high relapse rates, but cognitive-behavioral therapy and family-based treatment

45 en initiated after an acute episode, whereas cognitive-behavioral therapy and group psychoeducation a

46 Cognitive-behavioral therapy and interpersonal therapy h

47 onsive to psychosocial treatments, including cognitive-behavioral therapy and motivational enhancemen

48 boratory work continue to support the use of cognitive-behavioral therapy and operant behavioral ther

49 Cognitive-behavioral therapy and operant behavioral ther

50 Nonpharmacologic interventions such as cognitive-behavioral therapy and stress management may b

51 ore a 12-week randomized controlled trial of cognitive-behavioral therapy and/or contingency manageme

52 rmacological therapies (education, exercise, cognitive behavioral therapy) and pharmacological therap

53 tive treatments include psychotherapy (often cognitive behavioral therapy) and pharmacotherapy, such

54 ic antidepressants, cardiovascular exercise, cognitive behavioral therapy, and patient education.

55 terans with PTSD will receive evidence-based cognitive-behavioral therapy, and the Army has developed

56 underlies the exposure therapy component of cognitive-behavioral therapy approaches, which are ubiqu

57 amphetamine salts in robust doses along with cognitive behavioral therapy are effective for treatment

58 , family therapy, interpersonal therapy, and cognitive-behavioral therapy are described.

59 ms were also significantly more improved for cognitive behavioral therapy (beta = -0.41; 95% CI, -0.6

60 behavioral interventions and Internet-based cognitive-behavioral therapy both show promise for use i

61 ChRs) before and after treatment with either cognitive-behavioral therapy, bupropion HCl, or pill pla

62 ers is an integral element of trauma-focused cognitive behavioral therapy, but little is known about

63 Cognitive behavioral therapies (CBT) have been shown to

64 ically, included self-guided/minimal contact cognitive behavioral therapy (CBT) (RR, 0.71; 95% CI, 0.

65 A large study found that a combination of cognitive behavioral therapy (CBT) and antidepressant me

66 On the basis of moderate-strength evidence, cognitive behavioral therapy (CBT) and antidepressants l

67 parative effectiveness and adverse events of cognitive behavioral therapy (CBT) and pharmacotherapy f

68 Clinical guidelines recommend cognitive behavioral therapy (CBT) as a treatment for ti

69 Cognitive behavioral therapy (CBT) can reduce distress a

70 Cognitive behavioral therapy (CBT) for obsessive-compuls

71 n, can augment the effects of exposure-based cognitive behavioral therapy (CBT) for obsessive-compuls

72 Cognitive behavioral therapy (CBT) for social anxiety di

73 Applications of Fuzzy Trace Theory to Cognitive Behavioral Therapy (CBT) for youth at risk for

74 Clinician-guided online self-help based on cognitive behavioral therapy (CBT) has been shown to be

75 Cognitive behavioral therapy (CBT) has the most empirica

76 They ascertain that in cognitive behavioral therapy (CBT) high priority is give

77 3 randomized controlled trials of individual cognitive behavioral therapy (CBT) in a primary care set

78 analysis was used to estimate the benefit of cognitive behavioral therapy (CBT) in pregnant and postp

79 e superior EoT/FU in EP (SMD = -0.32/-0.21), cognitive behavioral therapy (CBT) in schizophrenia EoT/

80 Although cognitive behavioral therapy (CBT) is a first-line treat

81 Cognitive behavioral therapy (CBT) is an effective treat

82 Cognitive behavioral therapy (CBT) is an established evi

83 Cognitive behavioral therapy (CBT) is an evidence-based

84 Background Cognitive behavioral therapy (CBT) is the current standa

85 se We evaluated the effect of Internet-based cognitive behavioral therapy (CBT) on sexual functioning

86 emotional faces is a promising biomarker of cognitive behavioral therapy (CBT) outcome in patients w

87 We determined whether individual cognitive behavioral therapy (CBT) reduces depression in

88 or psychological interventions suggests that cognitive behavioral therapy (CBT) reduces suicide attem

89 Cognitive behavioral therapy (CBT) reduces the effect of

90 Although cognitive behavioral therapy (CBT) represents the criter

91 Cognitive behavioral therapy (CBT) skills training inter

92 Before cognitive behavioral therapy (CBT), 48 adults (25 GAD an

93 Depression Study evaluated fluoxetine (FLX), cognitive behavioral therapy (CBT), and FLX/CBT combinat

94 luoxetine, the combination of fluoxetine and cognitive behavioral therapy (CBT), and interpersonal th

95 CALM allowed choice of cognitive behavioral therapy (CBT), medication, or both;

96 e of our study was to evaluate the effect of cognitive behavioral therapy (CBT), physical exercise (P

97 brain structure in patients with PTSD after cognitive behavioral therapy (CBT).

98 a second-generation antidepressant (SGA) or cognitive behavioral therapy (CBT).

99 to predict subsequent treatment response to cognitive behavioral therapy (CBT).

100 o assess the clinical efficacy and safety of cognitive-behavioral therapy (CBT) against education (ED

101 tcomes of two active treatments, maintenance cognitive-behavioral therapy (CBT) and manualized psycho

102 tromedial prefrontal cortex (PFC)] predicted cognitive-behavioral therapy (CBT) and selective seroton

103 The authors evaluated the efficacy of cognitive-behavioral therapy (CBT) and two antidepressan

104 nced treatment combining pharmacotherapy and cognitive-behavioral therapy (CBT) boosts response and p

105 review, the authors examine the efficacy of cognitive-behavioral therapy (CBT) for adolescents with

106 l quality of randomized controlled trials of cognitive-behavioral therapy (CBT) for depression using

107 posure and ritual prevention, an established cognitive-behavioral therapy (CBT) for OCD.

108 This case study describes cognitive-behavioral therapy (CBT) for pathological gamb

109 the efficacy of a computer-based version of cognitive-behavioral therapy (CBT) for substance depende

110 authors evaluated the effectiveness of brief cognitive-behavioral therapy (CBT) for the prevention of

111 Cognitive-behavioral therapy (CBT) has been hypothesized

112 Cognitive-behavioral therapy (CBT) has documented effica

113 epressant medication after nonremission with cognitive-behavioral therapy (CBT) has received little s

114 Cognitive-behavioral therapy (CBT) has shown efficacy in

115 Various approaches to cognitive-behavioral therapy (CBT) have been shown to be

116 d accelerates a full course of comprehensive cognitive-behavioral therapy (CBT) in adults with genera

117 We examined the effects of cognitive-behavioral therapy (CBT) in patients with anxi

118 ther long-term treatment with doxycycline or cognitive-behavioral therapy (CBT) in reducing fatigue s

119 are probably slightly smaller than those of cognitive-behavioral therapy (CBT) in the acute phase of

120 rs compared psychoanalytic psychotherapy and cognitive-behavioral therapy (CBT) in the treatment of b

121 ects of a 10-session, telephone-administered cognitive-behavioral therapy (CBT) intervention on PTSD,

122 Although exposure-based cognitive-behavioral therapy (CBT) is an effective treat

123 Cognitive-behavioral therapy (CBT) is an effective treat

124 Cognitive-behavioral therapy (CBT) is effective for pedi

125 Research suggests that cognitive-behavioral therapy (CBT) is the most effective

126 tention bias modification therapy (ABMT) and cognitive-behavioral therapy (CBT) may have complementar

127 ion of up to 6 sessions (across 12 weeks) of cognitive-behavioral therapy (CBT) modified for the prim

128 ive imipramine, up to 300 mg/d, only (n=83); cognitive-behavioral therapy (CBT) only (n=77); placebo

129 pressive disorder in adolescents may include cognitive-behavioral therapy (CBT) or a selective seroto

130 form the first-line treatment choice between cognitive-behavioral therapy (CBT) or an antidepressant

131 e depressed patient benefits moderately from cognitive-behavioral therapy (CBT) or pharmacotherapy, s

132 moderator and index of symptom change during cognitive-behavioral therapy (CBT) or selective serotoni

133 Behavioral therapy and cognitive-behavioral therapy (CBT) programs targeting a

134 trategy of fluoxetine and relapse-prevention cognitive-behavioral therapy (CBT) to determine effects

135 ms irrespective of diagnosis, trauma-focused cognitive-behavioral therapy (CBT) was more effective th

136 Cognitive-behavioral therapy (CBT) was significantly mor

137 andomized clinical trial was to test whether cognitive-behavioral therapy (CBT) was superior to fibro

138 Pharmacotherapy, cognitive-behavioral therapy (CBT), and psychodynamic th

139 te the relative effectiveness of fluoxetine, cognitive-behavioral therapy (CBT), and the combination

140 ) evaluates the effectiveness of fluoxetine, cognitive-behavioral therapy (CBT), and their combinatio

141 itial 12 weeks of treatment with fluoxetine, cognitive-behavioral therapy (CBT), combination treatmen

142 ficacy of psychodynamic therapy with that of cognitive-behavioral therapy (CBT), hypothesizing nonsig

143 orted findings of a clinical trial comparing cognitive-behavioral therapy (CBT), psychodynamic therap

144 ne the efficacy of individually administered cognitive-behavioral therapy (CBT), relative to clinical

145 der in adults can be successfully treated by cognitive-behavioral therapy (CBT), there is no evidence

146 participants with OCD completed a course of cognitive-behavioral therapy (CBT).

147 ve serotonin reuptake inhibitors (SSRIs) and cognitive-behavioral therapy (CBT).

148 ve serotonin reuptake inhibitors (SSRIs) and cognitive-behavioral therapy (CBT).

149 or venlafaxine) or a medication switch plus cognitive-behavioral therapy (CBT).

150 ke inhibitor or venlafaxine, with or without cognitive-behavioral therapy (CBT).

151 dependence: contingency management (CM) and cognitive-behavioral therapy (CBT).

152 strated benefits for pharmacotherapy and for cognitive-behavioral therapy (CBT).

153 ral therapy (CCBT) in comparison to standard cognitive-behavioral therapy (CBT).

154 All studies involved cognitive-behavioral therapy (CBT).

155 s before and after symptom reduction through cognitive-behavioral therapy (CBT).

156 eks of treatment with either escitalopram or cognitive-behavioral therapy (CBT).

157 trial evaluating computer-based training for cognitive-behavioral therapy (CBT4CBT) in 77 heterogeneo

158 Effects at postintervention of contemporary cognitive behavioral therapies (CBTs; g = 0.42) were lar

159 recommended in combination with established cognitive-behavioral therapies (CBTs) for posttraumatic

160 apist-supported method for computer-assisted cognitive-behavioral therapy (CCBT) in comparison to sta

161 symptoms treated with medication, the use of cognitive behavioral therapy compared with relaxation wi

162 A randomized clinical trial of cognitive-behavioral therapy compared with supportive th

163 Responders and partial responders in the cognitive behavioral therapy condition maintained their

164 uidelines recommend adding antipsychotics or cognitive-behavioral therapy consisting of exposure and

165 sician management, physician management plus cognitive behavioral therapy, contingency management, co

166 aimed to develop and evaluate a computerized cognitive-behavioral therapy dental anxiety intervention

167 aimed at increasing cognitive control using cognitive behavioral therapies dependent on the intact d

168 s used to compare the efficacy of manualized cognitive-behavioral therapy developed particularly for

169 onding to chronic stress, and trauma-focused cognitive behavioral therapy documents that these treatm

170 and substance use as well as medication and cognitive behavioral therapy elements targeting PTSD and

171 of modalities, including behavioral therapy, cognitive-behavioral therapy, emotion-focused therapy, a

172 udies of fluoxetine, combined fluoxetine and cognitive behavioral therapy, escitalopram, and collabor

173 severe and persistent PTS via trauma-focused cognitive behavioral therapy; evidence is lacking for ps

174 Cognitive behavioral therapy, exercise, and SSRIs may re

175 We found good evidence that cognitive-behavioral therapy, exercise, spinal manipulat

176 cy for chronic or subacute low back pain are cognitive-behavioral therapy, exercise, spinal manipulat

177 Recent studies showed that cognitive-behavioral therapy failed to produce superior

178 Treatment with cognitive-behavioral therapy, fluoxetine hydrochloride,

179 ions, DBS could augment the effectiveness of cognitive behavioral therapies for OCD.

180 d controlled trial assessing the efficacy of cognitive behavioral therapy for 86 symptomatic adults w

181 h should assess the delivery of manual-based cognitive behavioral therapy for anxiety disorders by me

182 cognitive behavioral therapy for depression, cognitive behavioral therapy for anxiety, and behavioral

183 and there were more treatment responders in cognitive behavioral therapy for both the Clinical Globa

184 Cognitive behavioral therapy for chronic pain (CBT-CP) i

185 atment with residential treatment plus group cognitive behavioral therapy for depression delivered by

186 Providing group cognitive behavioral therapy for depression to clients w

187 al treatment (59 youths [34% of the sample]; cognitive behavioral therapy for depression, cognitive b

188 Sixteen 2-hour group sessions of cognitive behavioral therapy for depression.

189 dults with chronic insomnia disorder in whom cognitive behavioral therapy for insomnia (CBT-I) alone

190 Purpose Cognitive behavioral therapy for insomnia (CBT-I) and Ta

191 P recommends that all adult patients receive cognitive behavioral therapy for insomnia (CBT-I) as the

192 ed stress reduction (MBSR) is noninferior to cognitive behavioral therapy for insomnia (CBT-I) for th

193 Cognitive behavioral therapy for insomnia (CBT-I) has be

194 Cognitive behavioral therapy for insomnia (CBT-I) improv

195 ts associated with pharmacologic approaches, cognitive behavioral therapy for insomnia (CBT-i) is now

196 Cognitive behavioral therapy for insomnia (CBT-I) is rec

197 Although cognitive behavioral therapy for insomnia (CBT-I) is the

198 Cognitive behavioral therapy for insomnia (CBT-I) is the

199 Cognitive behavioral therapy for insomnia (CBT-I), compr

200 elated stimuli (SS), which can be treated by cognitive behavioral therapy for insomnia (CBT-I).

201 ticularly in older adults) and administering cognitive behavioral therapy for insomnia (CBTI) as firs

202 Cognitive behavioral therapy for insomnia (CBTi) is the

203 nd (3) evidence-based pharmacotherapy and/or cognitive behavioral therapy for patients with persisten

204 avioral interventions for trauma in schools, cognitive behavioral therapy for PTSD, structured psycho

205 t, and utilize functional rehabilitation and cognitive behavioral therapy for the individual and fami

206 re recommended in conjunction with drugs and cognitive behavioral therapy for the treatment of impair

207 ffecting other neurotransmitter systems, and cognitive behavioral therapy for the treatment of pediat

208 ults with insomnia were randomly assigned to cognitive-behavioral therapy for insomnia (CBT-I), tai c

209 for insomnia, typically delivered as part of cognitive-behavioral therapy for insomnia (CBT-I).

210 r seasonal affective disorder (SAD), data on cognitive-behavioral therapy for SAD (CBT-SAD) are promi

211 h as fear of reinjury) and the adaptation of cognitive-behavioral therapy for special pain groups (e.

212 Cognitive behavioral therapy (g = -0.20) and mindfulness

213 t group, children in the social learning and cognitive behavioral therapy group reported greater base

214 rt group, parents in the social learning and cognitive behavioral therapy group reported greater base

215 52 of 77 participants (68%) in the in-person cognitive behavioral therapy group were classified as tr

216 Cognitive behavioral therapy has been shown to be more e

217 Enhanced cognitive behavioral therapy has improved symptoms in ad

218 Self-guided internet-based cognitive behavioral therapy (iCBT) has the potential to

219 tudy of a newly developed internet-delivered cognitive behavioral therapy (ICBT) that emphasized expo

220 We evaluated the effect of Internet-based cognitive behavioral therapy (iCBT), with or without the

221 ive treatment strategy in Internet-delivered cognitive-behavioral therapy (ICBT), where risk of treat

222 tenance pharmacotherapy with varenicline and cognitive behavioral therapy improved prolonged tobacco

223 Both physical exercise training and cognitive behavioral therapy improved rate of oxygen con

224 y across both groups, as well as response to cognitive-behavioral therapy in a subset of 53 patients.

225 Research evidence supports the efficacy of cognitive-behavioral therapy in the treatment of drug-re

226 Approaches to treatment should include cognitive-behavioral therapy (including habit reversal o

227 on is based on well-established face-to-face cognitive behavioral therapy incorporating the primary c

228 lexible-dose sertraline hydrochloride) only, cognitive behavioral therapy informed psychotherapy (CBT

229 Brief cognitive behavioral therapy-inpatient reduced 6-month p

230 Brief cognitive behavioral therapy-inpatient reduced the occur

231 A 3-session social learning and cognitive behavioral therapy intervention or an educatio

232 Prior research suggests that cognitive behavioral therapy is a particularly effective

233 Cognitive behavioral therapy is an effective treatment f

234 nd well to the use of an antidepressant, and cognitive-behavioral therapy is a useful approach for ma

235 Cognitive-behavioral therapy is effective in treating ne

236 At present, cognitive-behavioral therapy is the psychological treatm

237 e of the most effective insomnia treatments, cognitive behavioral therapy, is significantly limited.

238 Cognitive behavioral therapy, lisdexamfetamine, SGAs, an

239 at extinction procedures, via exposure-based cognitive behavioral therapy, make up one of the predomi

240 ndary analyses suggest that bupropion SR and cognitive behavioral therapy may be effective treatments

241 Behaviorally focused therapies, including cognitive behavioral therapy, may be effective, especial

242 ths were randomized to 1 of 4 interventions (cognitive behavioral therapy, medication, combination, o

243 component intervention, psychoeducation, and cognitive behavioral therapy might reduce depression.

244 ceiving supportive psychotherapy (n = 24) or cognitive behavioral therapy (n = 27).

245 , a self-help booklet based on principles of cognitive behavioral therapy (n = 28), or repeated asses

246 he effect of nortriptyline hydrochloride and cognitive-behavioral therapy on smoking treatment outcom

247 psychosocial interventions for chronic pain: cognitive-behavioral therapy, operant behavioral therapy

248 ndomized to 12 individual sessions of either cognitive behavioral therapy or relaxation with educatio

249 mmends that clinicians select between either cognitive behavioral therapy or second-generation antide

250 interpersonal and social rhythm therapy, or cognitive-behavioral therapy) or collaborative care, a t

251 mg per day), a combination of sertraline and cognitive behavioral therapy, or a placebo drug for 12 w

252 k, low-level laser therapy, operant therapy, cognitive behavioral therapy, or spinal manipulation (lo

253 massage therapy, spinal manipulation, yoga, cognitive-behavioral therapy, or progressive relaxation

254 for combination therapy (P<0.001), 59.7% for cognitive behavioral therapy (P<0.001), and 54.9% for se

255 Cognitive behavioral therapy plus a switch to either med

256 ion were randomized and received 12 weeks of cognitive behavioral therapy plus either fluoxetine or p

257 ve of this study was to test the efficacy of cognitive-behavioral therapy plus hypnosis (CBTH) to con

258 In addition, cognitive-behavioral therapy plus medication was superio

259 interventions for anxiety disorders, such as cognitive behavioral therapy, primarily rely on mechanis

260 Cognitive behavioral therapy produced larger improvement

261 y intervention added an 8-session structured cognitive behavioral therapy program with up to 4 additi

262 Cognitive behavioral therapy rapidly affects automatic p

263 Cognitive behavioral therapy reduced primary anxiety sym

264 No further improvement followed cognitive behavioral therapy, reflecting a floor effect

265 , or social phobia to receive 14 sessions of cognitive behavioral therapy, sertraline (at a dose of u

266 sted of 5 weekly psychologist-led video tele-cognitive behavioral therapy sessions.

267 vioral category, graded exercise therapy and cognitive behavioral therapy showed positive results and

268 ency management, contingency management plus cognitive behavioral therapy, standard medical managemen

269 erventions with interpersonal psychotherapy, cognitive behavioral therapy, supportive psychotherapy,

270 icant differences in long-term outcome among cognitive behavioral therapy, systematic behavioral fami

271 order randomly assigned to 12 to 16 weeks of cognitive behavioral therapy, systemic behavioral family

272 udies have shown that telephone-administered cognitive-behavioral therapy (T-CBT) is superior to form

273 suggest better long-term outcomes following cognitive-behavioral therapy tailored for SAD (CBT-SAD)

274 Adapting well-established cognitive-behavioral therapies targeting social anxiety

275 lowing percentages of the overall variation: cognitive-behavioral therapy techniques, 16%; family the

276 lowing percentages of the overall variation: cognitive-behavioral therapy techniques, 23%; family the

277 attitudes were more likely to endorse use of cognitive-behavioral therapy techniques, as were those i

278 , sedation, and restlessness associated with cognitive behavioral therapy than with sertraline.

279 ndomly assigned to a 10-session standardized cognitive-behavioral therapy (the Cognitive-Behavioral I

280 entions (fluoxetine hydrochloride treatment, cognitive behavioral therapy, their combination, or plac

281 omen in Washington, District of Columbia, to cognitive behavioral therapy vs. usual care to decrease

282 This was a 2 (nortriptyline vs placebo) x 2 (cognitive-behavioral therapy vs control) x 2 (history of

283 Group comprehensive cognitive behavioral therapy was administered weekly for

284 Cognitive behavioral therapy was associated with fewer d

285 eters were achieved and adjunctive inpatient cognitive behavioral therapy was delivered.

286 synergistic benefit of DBS at both sites and cognitive behavioral therapy was explored.

287 Cognitive behavioral therapy was provided weekly during

288 Cognitive behavioral therapy was the EBT most frequently

289 Cognitive-behavioral therapy was more effective for part

290 Cognitive-behavioral therapy was significantly more rapi

291 Cognitive-behavioral therapy was significantly superior

292 Cognitive-behavioral therapy was superior to supportive

293 als registation: "Computer-based training in cognitive-behavioral therapy web-based (Man VS Machine)"

294 ressive symptoms, whereas family therapy and cognitive-behavioral therapy were more effective for dep

295 he efficacy of online-based dissemination of cognitive behavioral therapies, which have demonstrated

296 bination therapy had a greater response than cognitive behavioral therapy, which was equivalent to se

297 Besides psycho-pharmacotherapy, cognitive behavioral therapy with an exposure-based appr

298 ts with bulimia nervosa who had responded to cognitive behavioral therapy with complete abstinence fr

299 Although cognitive behavioral therapy with or without selective s

300 To compare prolonged exposure, a type of cognitive behavioral therapy, with present-centered ther